Microcephaly Panel
New York
Approved
Genes
Conditions
- Microcephaly
- Primary AR microcephaly
- Rubinstein-Taybi syndrome (RSTS)
- Warburg Micro Syndrome
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Establish the type of microcephaly and cause in order to provide information regarding prognosis, management and recurrence risk.
- Testing of at-risk relatives for specific known pathogenic variant(s) previously identified in an affected family member
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
689
CPT Codes*
81404x2, 81405x3, 81406x4, 81407x1, 81408x1, 81479x1, 81175x1, 81302x1, 81304x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing